GH Research Ownership

GHRS Stock  USD 8.60  0.37  4.12%   
GH Research PLC secures a total of 52.03 Million outstanding shares. Over half of GH Research's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as GH Research in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of GH Research, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Paid And Capex Coverage Ratio is likely to drop to -350.03 in 2024. Common Stock Shares Outstanding is likely to drop to about 47.4 M in 2024. Net Loss is likely to gain to about (19.2 M) in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GH Research PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

GHRS Stock Ownership Analysis

About 40.0% of the company shares are held by company insiders. The book value of GH Research was currently reported as 4.21. The company recorded a loss per share of 0.79. GH Research PLC had not issued any dividends in recent years. GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland. Gh Research is traded on NASDAQ Exchange in the United States. To learn more about GH Research PLC call Theis MD at 353 1 437 8334 or check out https://www.ghres.com.
Besides selling stocks to institutional investors, GH Research also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different GH Research's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align GH Research's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

GH Research Quarterly Liabilities And Stockholders Equity

199.61 Million

About 40.0% of GH Research PLC are currently held by insiders. Unlike GH Research's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against GH Research's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of GH Research's insider trades

GHRS Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as GH Research is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GH Research PLC backward and forwards among themselves. GH Research's institutional investor refers to the entity that pools money to purchase GH Research's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Blackrock Inc2024-06-30
60.5 K
Laurion Capital Management Lp2024-09-30
48.4 K
Alps Advisors Inc2024-09-30
38.4 K
Woodline Partners Lp2024-09-30
37.2 K
Northern Trust Corp2024-09-30
32.2 K
Advisorshares Investments, Llc2024-09-30
31.2 K
Renaissance Technologies Corp2024-09-30
30.4 K
Bank Of America Corp2024-09-30
28.1 K
Barclays Plc2024-09-30
K
Bvf Inc2024-09-30
10.4 M
Ra Capital Management, Llc2024-09-30
6.7 M
Note, although GH Research's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

GH Research Outstanding Bonds

GH Research issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GH Research PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GHRS bonds can be classified according to their maturity, which is the date when GH Research PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

GH Research Corporate Filings

6K
5th of December 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
7th of March 2024
Other Reports
ViewVerify
13A
16th of February 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for GHRS Stock Analysis

When running GH Research's price analysis, check to measure GH Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GH Research is operating at the current time. Most of GH Research's value examination focuses on studying past and present price action to predict the probability of GH Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GH Research's price. Additionally, you may evaluate how the addition of GH Research to your portfolios can decrease your overall portfolio volatility.